Ophthalmology

Neoadjuvant Uveal Melanoma Monotherapy Darovasertib Granted Breakthrough Drug Status

Ophthalmology

Uveitis Advancements: Priovant Therapeutics Secures FDA Fast Track for Brepocitinib and Begins Phase 3 Study

Rare Diseases

FDA Approves Ctexli: First Treatment for Cerebrotendinous Xanthomatosis

Rare Diseases, Neurology

 FINTEPLA® (Fenfluramine) Approved for Dravet Syndrome: Long-Term Study Confirms Safety and Efficacy

About Us

The Medical Education Network is an independent, free-for-use resource for healthcare practitioners in sub-Saharan Africa.

We provide a range of quality clinical information sourced from peer-reviewed journals and original articles to facilitate continued medical education and knowledge sharing.

If you would like to be involved with our programs or contribute to our site, please contact us

Our Policies

Your information and the quality of our content are important to us.

Our policies are listed below. If you have any concerns, please contact us

Privacy Policy
Acceptable Use Policy
Cookies and how we use them
General Information relating to your data
Fact-Checking and General Content Disclaimers

Contact Us

Sign-up for our Newsletters
General Site Queries
Advertising & Sponsorship Queries
Contributors & Authors


Follow us on our Social Media platforms